IRhythm Technologies Net Cash Flow 2015-2025 | IRTC

IRhythm Technologies net cash flow for the twelve months ending June 30, 2025 was $0.729B, a 22.59% decline year-over-year.

  • IRhythm Technologies annual net cash flow for 2024 was $0.392B, a 1018.4% decline from 2023.
  • IRhythm Technologies annual net cash flow for 2023 was $-0.043B, a 12.46% decline from 2022.
  • IRhythm Technologies annual net cash flow for 2022 was $-0.049B, a 225.16% decline from 2021.

IRhythm Technologies Net Cash Flow 2015-2025 | IRTC

  • IRhythm Technologies annual net cash flow for 2024 was $0.392B, a 1018.4% decline from 2023.
  • IRhythm Technologies annual net cash flow for 2023 was $-0.043B, a 12.46% decline from 2022.
  • IRhythm Technologies annual net cash flow for 2022 was $-0.049B, a 225.16% decline from 2021.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.6B
Tempus AI (TEM)$13.2B
Doximity (DOCS)$12.4B
Hims & Hers Health (HIMS)$9.7B
Hinge Health (HNGE)$4.3B
Inspire Medical Systems (INSP)$2.7B
Privia Health (PRVA)$2.6B
Heartflow (HTFL)$2.4B
Phreesia (PHR)$1.8B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$659M
Zepp Health (ZEPP)$570M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$474M
Talkspace (TALK)$445M
Butterfly Network (BFLY)$390M
Carlsmed (CARL)$380M
TruBridge (TBRG)$298M
Outset Medical (OM)$244M
Health Catalyst (HCAT)$235M
SOPHiA GENETICS SA (SOPH)$233M
Nyxoah SA (NYXH)$220M
KORU Medical Systems (KRMD)$194M